Pressroom

Trending Topics

 

Check out the latest cancer-related news and also see who is readily available to offer reliable information, expert commentary, and reaction to today's headlines.
Contact a media coordinator

Thousands of oncology experts from around the world will gather in Chicago from April 14 - 18 for the AACR Annual Meeting. Memorial Sloan Kettering experts are involved in notable research presented at the meeting and are available to comment on precision medicine, immunotherapy, interception and prevention, liquid biopsies, genomics and more. For more information and to set up interviews or access photos and video, email Nicole H. McNamara at mcnamarn@mskcc.org.
Thursday, April 12, 2018
 
Visible Ink at Memorial Sloan Kettering Cancer Center (MSK) is the leading — and largest — writing program of its kind. Writing promotes creativity, reduces stress, and empowers people with cancer to give voice to their stories.
Friday, April 6, 2018
 
Larotrectinib, a highly selective TRK kinase inhibitor, shows rapid, potent, and durable efficacy in both adult and pediatric patients with solid tumors that harbor TRK fusions, regardless of tumor type or patient age, according to results from three clinical trials published in the New England Journal of Medicine. The landmark data support the foundation of precision oncology by creating a treatment option for a genetically defined cancer while continuing to validate the concept that comprehensive molecular profiling should be strongly considered in people of all ages with advanced solid tumors.
Wednesday, February 21, 2018
 

See all trending topics
 

Press Releases

 

Researchers at Memorial Sloan Kettering (MSK) reported results, which were highlighted at the American Society of Clinical Oncology (ASCO) press cast, that eight weeks of acupuncture or cognitive behavioral therapy for insomnia (CBT-I) decreased the severity of insomnia in cancer survivors. While both acupuncture and CBT-I resulted in clinically meaningful and durable effects among this group, CBT-I was more effective, especially among people with mild insomnia symptoms.
Wednesday, May 16, 2018
 
Researchers at Memorial Sloan Kettering (MSK) report that firefighters at the World Trade Center (WTC) scene in September 2001 were nearly twice as likely as the general population to have a multiple myeloma precursor condition called monoclonal gammopathy of undetermined significance (MGUS). This new research was published online today in JAMA Oncology.
Thursday, April 26, 2018
 
Memorial Sloan Kettering Cancer Center (MSK) has announced that Debra Berns has been named as MSK’s Senior Vice President and Chief Risk Officer following an extensive national search.
Wednesday, April 18, 2018
 

See all press releases
 

On Our Blog

 

IN THE CLINIC
Preliminary results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe.
Thursday, May 17, 2018
 
IN THE CLINIC
MSK dermatologists are using noninvasive imaging methods to detect skin cancer and guide its treatment.
Thursday, May 17, 2018
 
FINDING
Learn about ways that you can reduce insomnia without medication.
Wednesday, May 16, 2018
 

See all blog posts
 

Media Coverage

 

Women with breast cancer whose quality of life is negatively impacted by endocrine therapy-induced alopecia (EIA) from may benefit from minoxidil, researchers suggest. MSK’s Mario Lacouture and colleagues studied 112 women with breast cancer diagnosed with EIA at their hospital from 2009-2016.
Thursday, April 19, 2018
 
Researchers report some of the most encouraging results yet for treating lung cancer with the latest immune-based treatments, most of which have been approved to treat other types of tumors. In one of the studies published led by MSK’s Matthew Hellmann, researchers used two immunotherapy medications — Opdivo and Yervoy, both made by Bristol-Myers Squibb — to treat newly diagnosed patients with advanced non-small cell lung cancer with a high number of mutations in their tumors. 
Monday, April 16, 2018
 
MSK’s Andrea Cercek discusses the rise in colorectal cancer among people under 50 and MSK’s new Center for Young Onset Colorectal Cancer.
Friday, March 30, 2018
 

See all media coverage
 

If you wish to contact MSK about a marketing or advertising related opportunity, or are looking for additional information about our ad campaign, please email us at marketing@mskcc.org.

For Journalists

Jeanne D'Agostino
Director, Media and Public Relations
 
Emily O'Donnell
Media Relations Manager, Surgery
 
Courtney Nowak
Media Relations Manager, Regional Care Network
 
Caitlin Hool
Senior Manager, Media Relations and Partnerships
 
Nicole H. McNamara
Senior Media Strategist
 
Rebecca Williams
Media Strategist
 
For press inquiries, our Media Staff are available by calling 646-227-3573 or by dialing the numbers above. Our office hours are Monday - Friday, 9:00 AM to 5:00 PM.
 
After hours, please contact the hospital's page operator at 212-639-7900 and ask for the Public Affairs representative on-call.

Live and Remote Broadcast Capabilities

Our experts can offer live broadcast interviews using the on-site studio system. To book an expert interview using our on-site broadcast studio contact our Media Staff.